{
    "nctId": "NCT04563013",
    "briefTitle": "Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients",
    "officialTitle": "Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients' Fatigue, Quality of Life and Lymphopenia After Radiotherapy or Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Cancer, Therapy-Related, Cancer-related Fatigue, Quality of Life",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 261,
    "primaryOutcomeMeasure": "the score of fatigue at 1 month",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Participants diagnosed with breast cancer, suitable for adjuvant radiotherapy after surgery;\n2. Eastern Cooperative Oncology Group (ECOG) physical condition score: 0\\~1 point.\n\nExclusion Criteria:\n\n1. Participants with organic brain lesions (cerebral hemorrhage, large-area cerebral infarction, encephalitis, epilepsy, etc.);\n2. Participants with peptic ulcer, arrhythmia, or cardiac corrected QT interval\\> 450ms;\n3. Participants who have slow breathing (less than 10 breaths per minute);\n4. Participants who are or have been diagnosed with other major diseases (coronary heart disease, pulmonary heart disease, etc.);\n5. Participants who are currently or have been diagnosed with mental disorders other than major depressive disorder;\n6. Participants who are or have participated in vagus nerve or transcranial electrical stimulation treatment for less than 3 months;\n7. Participants who are not suitable for vagus nerve stimulation treatment;\n8. Participants who refuse to sign informed consent.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}